TP53 and neoplasm: In line with these findings, and despite showing a similar rate of tumor development, NLRC5 overexpression in the ID8-p53−/− model shapes the orthotopic and ascitic TME, increasing T-cell activation as shown by PD-1 and PD-L1 expression in T lymphocytes and APCs, respectively.